Replimune REPL
NASDAQ REPL
$11.72 +0.30 (+2.63%)
At close: Oct 21, 2026 · 4:00 PM EDT

Replimune (REPL) Tax Provisions (2023 - 2026)

Updated

Replimune's Tax Provisions came in at -$289,000 for fiscal Q4 2026 (quarter ended Mar 31, 2026), compared with -$100,000 a year earlier.

Analysis

Replimune (REPL) Tax Provisions (2023 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Replimune's Tax Provisions was -$600,000.

  • Going back by fiscal year, Tax Provisions was $500,000 in FY2025 (+22.5%), $408,000 in FY2024 (+36.0%) and $300,000 in FY2023.
  • The five-year range for quarterly Tax Provisions is -$311,000 (fiscal Q3 2026) to $600,000 (fiscal Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.21 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 662.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 291.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 242.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -407.00 Mn
10 Replimune 1.14 Bn 79.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -289,000.00
Dec 31, 2025 -311,000.00
Mar 31, 2025 -100,000.00
Dec 31, 2024 600,000.00
Mar 31, 2024 -92,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 -201,000.00
Jun 30, 2023 201,000.00
Mar 31, 2023 300,000.00
API Access

Replimune Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=REPL&period=max&api_key=YOUR_API_KEY